Catalent can advance your Phase 1 and 2 drug product programs through the clinic powered by industry experts and leading technologies. Contact us today to discuss your project: https://ow.ly/3eAC50SSsjk
Catalent Pharma Solutions
Fabbricazione di prodotti farmaceutici
Somerset, NJ 269.972 follower
more products. better treatments. reliably supplied. ™
Chi siamo
Catalent Inc. (NYSE: CTLT), an S&P 500® company, is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent supports our partners in introducing 200 new products and manufacturing over 70 billion doses each year. Since becoming a publicly traded company in 2014, we have grown to become a community of approximately 19,000+ workers who support over 7,000 products for over 1,000 customers around the world. We share a common goal: to put patients first and help people around the world live better and healthier lives. Catalyst + Talent. Our name combines these ideas. From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. We have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing and packaging results. more products. better treatments. reliably supplied.™ Your talents, ideas, and passion are essential to our mission: to develop, manufacture, and supply products that help people live better, healthier lives. Join us! Catalent hires people with a passion to make a difference to the health of millions of people globally. Your expertise, coupled with Catalent’s advanced technologies and collaboration with thousands of innovative pharmaceutical, biotech, and healthcare companies, will help bring life-enhancing products to life. Grow with us. Be challenged. Make a personal impact. Visit https://careers.catalent.com/us/en to explore career opportunities
- Sito Web
-
https://www.catalent.com
Link esterno per Catalent Pharma Solutions
- Settore
- Fabbricazione di prodotti farmaceutici
- Dimensioni dell’azienda
- Oltre 10.001 dipendenti
- Sede principale
- Somerset, NJ
- Tipo
- Società quotata
- Data di fondazione
- 2007
- Settori di competenza
- Analytical Chemistry, Clinical Supply, Biotech, Pharmaceutical Supply Chain, Biologics, Formulation Development, Drug Delivery, Clinical Packaging, Dose Form Manufacturing, Gene Therapy, Vaccine Production, Pharmaceutical, Drug Development, Cell Therapy, Biopharmaceutical e Innovation
Località
Dipendenti presso Catalent Pharma Solutions
Aggiornamenti
-
Catalent Biologics Madison facility serves pharmaceutical companies of all sizes with both early- and late-stage programs. In the article, Justin Koepsel, PhD, MBA, discusses how Catalent plays a crucial role in Wisconsin’s biopharmaceutical manufacturing sector. #Wisconsin #biotech https://ow.ly/5QpZ50SqpyV
-
-
Initiating clinical studies can be challenging and even more so when you are a small or new biotech. Turn to Catalent Biologics, a trusted sterile fill/finish partner for an efficient orchestration of your project with the right scale for your Phase 1 and 2 needs. https://ow.ly/Opac50TaZst
-
-
Gain insight into the latest trends for oral solid dose manufacturing and how computerized modelling tools can optimize costs and improve scale-up and efficiency. Read here: https://ow.ly/eqyQ50TBiEW
-
-
David McErlane, Group President of Biologics, and Aris Gennadios, Group President of Pharma and Consumer Health, share their expert views on how Catalent has forged long-term collaborations and partnerships that drive innovation in the CDMO space. Their insights are featured in a recent article by CHEManager which dives into the latest trends shaping the industry, including advanced manufacturing technologies, new regulatory shifts, and the growing emphasis on sustainability. Read the article here: https://ow.ly/RAvf50TE8F7 #CDMO #Pharma #Biotech #Manufacturing #Innovation #Sustainability
-
-
This on-demand webinar focuses on best practices that clinical trial sponsors can employ to build a functional relationship with their CRO, solidify a compelling clinical supply strategy, & drive alignment for success. Learn more and view today. https://ow.ly/oKai50THYUI
-
-
Join the Catalent Inhalation team in NYC for #RESCONSummit and hear Mark Ignaczak present on the latest trends in #nasal drug delivery. Be there to catch all the insights! Schedule a meeting today! https://ow.ly/mpJb50TN4OE
-
-
Join Catalent in Barcelona for #PEGS Europe Nov 5-7! Visit our booth 1002. Meet our Biologics experts and learn how we can accelerate your cell line & process development and drug substance manufacturing programs from the clinical phase to commercial. https://ow.ly/ksx850TQio6
-
-
Prefilled syringes (PFSs) are becoming the go-to for new injectable biologics. Transitioning from vial to PFS comes with its challenges. This article highlights the benefits and explores solutions for overcoming the pitfalls. https://ow.ly/xsQK50TJgch
-
-
“Amorphous solid dispersions, produced by spray-drying, are a proven choice to overcome poor bioavailability, and have been widely adopted,” said Lorenzo Carletti, President of Clinical Development and Supply, Catalent. Read more insights regarding our enhanced ASD capabilities in Catalent Boston in this featured article by Drug Development & Delivery here: https://ow.ly/hKvS50TW9zE
-
Pagine affiliate
Pagine simili
Sfoglia le offerte di lavoro
Raccolta fondi
Catalent Pharma Solutions
2 round in totale
Vedi altre informazioni su Crunchbase
Ultimo round
Debito post-IPO
Link al sito Crunchbase esterno per l’ultimo round di raccolta fondi
600.000.000,00 USD